Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD

Last updated: July 1, 2024
Sponsor: Brigham and Women's Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Bacterial Infections

Opioid Use Disorder

Treatment

Smart IOP Intervention

Peer Recovery Coach

Clinical Study ID

NCT05817825
2023P000709
R21DA056799
  • Ages > 18
  • All Genders

Study Summary

This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • English-speaking adults aged 18 and above

  • Any DSM-5 substance use disorder

  • Can identify at least 2 individuals who can act as points of contact followingdischarge from the hospital

Exclusion

Exclusion Criteria:

  • Psychotic disorder, active suicidality, or homicidally

  • Condition likely to be terminal during the study period

  • Unable to perform consent due to impaired mental status

Study Design

Total Participants: 20
Treatment Group(s): 2
Primary Treatment: Smart IOP Intervention
Phase:
Study Start date:
November 17, 2023
Estimated Completion Date:
December 31, 2024

Study Description

The aim is to conduct a single-arm pilot study of 20 participants who are hospitalized for serious injection-related infections to complete the newly tailored program. The intervention to be developed and tested has two components: 1) the remotely delivered IOP ("Smart IOP"), and 2) a peer recovery coach who will provide support and accountability to the participant. The feasibility of the intervention will be established by evaluating recruitment and the acceptability of the program according to a priori benchmarks. The study team will assess the program's preliminary efficacy by evaluating OUD-related outcomes for up to 28 days after discharge from the hospital. The study will be conducted at Brigham and Women's Hospital (BWH), an urban, 793-bed academic medical center located in Boston, MA, and a major teaching hospital for Harvard Medical School.

Connect with a study center

  • Brigham and Women's Hospital

    Boston, Massachusetts 02115
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.